9888:HKEXBaidu, Inc. Class A Analysis
Data as of 2026-05-29 - not real-time
HK$130.00
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Baidu’s price is comfortably above its short‑term and long‑term moving averages, indicating a prevailing bullish bias, while the MACD histogram remains in negative territory, signaling short‑term bearish momentum. The RSI hovers around the neutral zone, suggesting neither overbought nor oversold conditions, and volume trends are tapering, which could temper price advances.
On the fundamentals side, the company trades at a forward price‑to‑earnings multiple that is below the sector average and its price‑to‑book ratio hovers just above one, implying relative valuation comfort. A strong cash position more than offsets its debt load, yet profitability metrics remain thin and return figures are modest, highlighting execution risk. The stock’s beta is below one, pointing to lower systematic risk, but the sector faces medium regulatory scrutiny and the high recent volatility adds a layer of caution.
On the fundamentals side, the company trades at a forward price‑to‑earnings multiple that is below the sector average and its price‑to‑book ratio hovers just above one, implying relative valuation comfort. A strong cash position more than offsets its debt load, yet profitability metrics remain thin and return figures are modest, highlighting execution risk. The stock’s beta is below one, pointing to lower systematic risk, but the sector faces medium regulatory scrutiny and the high recent volatility adds a layer of caution.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bearish MACD histogram
- Decreasing volume trend
- Price above support but near resistance
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Forward PE below industry average
- Strong cash cushion relative to debt
- AI and cloud growth narrative
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Strategic positioning in AI and autonomous driving
- Undervalued valuation multiples compared with peers
- Resilient balance sheet with ample liquidity
Key Metrics & Analysis
Financial Health
Revenue Growth-1.20%
Profit Margin1.02%
P/E Ratio14.6
ROE0.32%
ROA1.25%
Debt/Equity32.20
P/B Ratio1.1
Op. Cash FlowHK$5.7B
Free Cash FlowHK$8.0B
Industry P/E17.0
Technical Analysis
TrendBullish
RSI51.4
SupportHK$117.00
ResistanceHK$147.90
MA 20HK$132.39
MA 50HK$122.29
MA 200HK$121.60
MACDBearish
VolumeDecreasing
Fear & Greed Index94.07
Valuation
Fair ValueHK$47.05
Target PriceHK$179.95
Upside/Downside38.42%
GradeFair
TypeBlend
Risk Assessment
Beta0.77
Volatility48.11%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.